More News

07 Jan 2023 Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US
06 Jan 2023 Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech
06 Jan 2023 Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
04 Jan 2023 NorthStar Medical Radioisotopes and Inhibrx Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Candidates
04 Jan 2023 Belharra Therapeutics Announces Broad Collaboration with Genentech to Discover and Develop Novel Medicines Across Multiple Therapeutic Areas
04 Jan 2023 Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO Therapies
03 Jan 2023 Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
02 Jan 2023 Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products Enabled by Alteogen’s Hybrozyme™ Technology
28 Dec 2022 PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates
28 Dec 2022 PeptiDream Announces New Research and Collaboration Agreement with Lilly for the Discovery of Novel Peptide Drug Conjugates
24 Dec 2022 LegoChem Biosciences and Amgen Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates
22 Dec 2022 Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer
22 Dec 2022 Lilly and ProQR to Expand RNA Editing Collaboration
20 Dec 2022 Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
19 Dec 2022 Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
15 Dec 2022 GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets
15 Dec 2022 Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
15 Dec 2022 Arthex announces regulatory milestones met in its program to develop ATX-01 in Myotonic Dystrophy Type 1
15 Dec 2022 Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease
14 Dec 2022 Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
12 Dec 2022 Amgen Inc to Acquire Horizon Therapeutics plc
08 Dec 2022 Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)
07 Dec 2022 MorphoSys Out Licenses Pre-Clinical Oncology Program
06 Dec 2022 Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy
06 Dec 2022 Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up